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Abstract
Background: Through modification of the flagellin type III secretion pathway of Bacillus halodurans heterologous
peptides could be secreted into the medium as flagellin fusion monomers. The stability of the secreted monomers
was significantly enhanced through gene-targeted inactivation of host cell extracellular proteases. In evaluating the
biotechnological potential of this extracellular secretion system an anti-viral therapeutic peptide, Enfuvirtide, was
chosen. Currently, Enfuvirtide is synthesised utilizing 106 chemical steps. We used Enfuvirtide as a model system in
an effort to develop a more cost-effective biological process for therapeutic peptide production.
Results: An attempt was made to increase the levels of the fusion peptide by two strategies, namely strain
improvement through gene-targeted knock-outs, as well as vector and cassette optimization. Both approaches
proved to be successful. Through chromosomal inactivation of the spo0A, lytC and lytE genes, giving rise to strain
B. halodurans BhFDL05S, the secretion of recombinant peptide fusions was increased 10-fold. Cassette optimization,
incorporating an expression vector pNW33N and the N- and C-terminal regions of the flagellin monomer as an in-
frame peptide fusion, resulted in a further 3.5-fold increase in the secretion of recombinant peptide fusions.
Conclusions: The type III flagellar secretion system of B. halodurans has been shown to successfully secrete a
therapeutic peptide as a heterologous flagellin fusion. Improvements to both the strain and expression cassette led
to increased levels of recombinant peptide, showing promise for a biotechnological application.
Background
Certain classes of pathogenic bacteria secrete virulence
proteins in a Sec-independent manner by means of a
type III secretion system (TTSS). Based on homologous
component proteins with common physico-chemical
properties the flagellin system was included as part of
the TTSS [1]. A feature of the TTSS that differentiates
it from other secretion systems is the lack of a defined
amino acid secretion signal to direct substrate proteins
for secretion. In addition, secretion occurs either across
the cell membranes or the cell wall through a channel
[2]. Most flagellar components are translocated across
the cytoplasmic membrane by the flagellar type III sys-
tem where they self- assemble at the distal end of the
flagellin channel with the help of a cap structure. Flagel-
lar proteins synthesized in the cytoplasm are targeted to
the export apparatus with the help of flagellum-specific
chaperones. The flagellin protein is then pushed into
the channel by an ATPase, whose activity is controlled
by its regulator to enable the energy of ATP hydrolysis
to be efficiently coupled to the translocation reaction
[3]. The flagellar type III secretion apparatus was found
to efficiently transport the flagellin subunit protein FliC
in both Gram-positive and Gram-negative bacteria. It
has been shown that Escherichia coli mutants with a
non-functional FliD protein (cap structure) fail to
assemble flagella and FliC monomers diffuse into the
culture medium [4]. Moreover, it was shown that an E.
coli mutant (defective in both the fliC and fliD genes)
was able to secrete heterologous polypeptide fusions
into the growth medium. This was facilitated by fusing a
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gene, as well as a transcriptional terminator from fliC
downstream of the gene encoding the polypeptide of
interest [4]. In a related approach, harnessing the Sal-
monella type III flagellin pathway, Végh et al [5] used a
Salmonella strain defective in flagellin gene expression,
but still apparently possessing a functional fliD gene to
show heterologous secretion of polypeptide-FliC fusions.
They demonstrated that a 22-residue long segment
within the disordered N-terminal region of Salmonella
flagellin contains the recognition signal for the flagellar
export machinery. Dobó et al [6] evaluated the secretion
of a number of different polypeptides using this system.
They found that the nature of the attached polypeptide
had a significant effect on secretion efficiency.
Bacillus halodurans Alk36 was found to over-produce
flagellin protein and this ability was utilized for the
development of a surface display system [7]. Berger et al
[ 8 ]d e m o n s t r a t e dt h a tw h e nt h ef l a g e l l i nt y p eI I Is e c r e -
tion pathway of this Gram-positive Bacillus strain was
modified by the inactivation of both the hag gene
(encoding FliC protein) and fliD gene (encoding the
FliD protein), then heterologous peptides could be
secreted into the medium as flagellin fusion monomers.
The gene encoding the human immunodeficiency virus
(HIV) subtype C antigenic peptide was fused as an in-
frame sandwich fusion into the central variable region
of the hag gene. The stability of the secreted flagellin
fusion monomers was shown to be significantly
enhanced through gene-targeted inactivation of five
proteases.
In evaluating the biotechnological potential of this
B. halodurans expression system, the anti-viral thera-
peutic peptide Enfuvirtide, currently marketed by Roche
under the trademark Fuzeon
®, was expressed. It is a
36-amino acid non-glycosylated synthetic peptide that
blocks HIV infection by preventing the virus from enter-
ing the cell. It is currently synthesised utilizing 106 che-
mical steps. The peptide is modified by acetylation at
the N-terminus and amidation at the C-terminus, which
enhances stability and efficiency of the peptide. This
complicated manufacturing process contributes towards
the high cost of the drug [9]. Therefore there is a clear
need to develop a cost-effective fermentation-based pro-
cess for recombinant therapeutic peptide production.
In this study, we report further refinements to the B.
halodurans host strain and expression cassette with a
view to improving expression levels of a therapeutic
peptide utilizing Enfuvirtide (Fuzeon
®) as a model sys-
tem. The Enfuvirtide peptide produced using a biologi-
cal route, by recombinant gene expression, would,
however, still need to be chemically modified for it to
be regarded as a biosimilar.
Methods
Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used in this study are
listed in Table 1. Growth conditions, DNA techniques
and B. halodurans transformation are described in
Crampton et al [7]. Recombinant B. halodurans strains
containing different constructs were grown in 50 ml of
Luria Bertani (LB) broth (pH 8.5, chloramphenicol
10 μg/ml; 30°C on an orbital shaker at 175 rpm).
Gene targeted inactivation of the spo0A, clpP, flgM and
aprX genes and the lytCE operon
Construction of mutant strains through gene-targeted
inactivation was as described in Berger et al [8]. Essen-
tially, this was achieved by creating a defective copy of
the gene of interest through PCR amplification of two
fragments containing part of the 5’ and 3’ regions of the
gene using chromosomal DNA from B. halodurans as
template. These fragments were ligated to the tempera-
ture sensitive vector pSEC194 transformed into the
appropriate B. halodurans strain and the targeted gene
partially deleted through a double-crossover event. Dele-
tions were confirmed through PCR analysis (results not
shown). The primers used to make these constructs are
listed in Table 2. The primers were designed based on
t h en u c l e o t i d es e q u e n c eo ft h er e l e v a n tg e n e sf r o mt h e
genome sequence for B. halodurans C125 available in the
DNA Data Bank of Japan (http://www.ddbj.nig.ac.jp/) and
is as follows: spo0A (BH2773), clpP (BH1930), flgM
(BH3632), aprX (BH1930) and the lytCE operon
(BH2665 and BH3671).
Gene cassette construction
Synthetic oligonucleotides (FuzF and FuzR, Table 2)
were derived from the Enfuvirtide amino acid sequence
(YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF)
and codon usage optimised for B. halodurans [10]. The
oligonucleotides were annealed according to the method
described by Integrated DNA Technologies http://www.
idtdna.com, digested with Sal 1 and Bam H1 and ligated
into pNW33N. In order to facilitate secretion, isolation
and purification of the recombinant peptide, expression
cassettes were developed as shown in Figure 1. Primers
used to amplify the various fragments of the flagellin
gene, the FLAG tag, the enterokinase cleavage site and
the Enfuvirtide sequence are detailed in Table 2. All
constructs were sequenced to confirm the desired DNA
sequence and the correct reading frame.
Western blotting and cell lysis determination
Samples were taken at different time points and the cell-
free culture supernatants were analysed for the presence
of fusion protein through SDS- PAGE and Western
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Gallagher et al [11] using Anti-FLAG M2 monoclonal
antibody peroxidase conjugate from Sigma-Aldrich at a
dilution of 1:2000 or rabbit polyclonal Anti-Enfuvirtide
antibodies conjugated to peroxidase obtained from
ANASPEC at a dilution of 1:1000. TMB (3,3’,5,5’-Tetra-
methylbenzidine) solution (Sigma-Aldrich, Cat# T0565)
was used for colour detection according to the manufac-
turer’s specifications. As a control against the possibility
that the heterologous fusion proteins in the growth
medium could be a result of leakage or lysis from the
cells, we analyzed intracellular and cell-free supernatant
samples by Western blot analysis using a chlorampheni-
col acetyltransferase antibody (Abcam) at a dilution of
1:10 000 [4]. Intracellular samples were prepared as fol-
lows: cell cultures (5 ml) were centrifuged, the pellet
resuspended in phosphate buffer (5 ml), sonicated for
3 × 5 min, centrifuged and 20 μl of supernatant evalu-
ated on SDS-PAGE gel.
Analysis of fusion protein concentrations
An ELISA plate assay using Anti-FLAG M2 monoclonal
antibody peroxidase conjugate (1:5000) (Sigma A8592)
was used to determine fusion protein concentrations.
The procedure is based on direct adsorption of the
fusion protein onto an ELISA plate. Cell free superna-
tant samples were used for analysis. The assay was
essentially carried out according to the manufacturer’s
specifications (Sigma-Aldrich). For detection the sub-
strate ABTS (2,2’-Azino-bis[3-ethylbenzo thiazoline-
6-sulfonic acid]diammonium salt) (Sigma A1888) was
dissolved (3 mg/10 ml) in citric acid (0.05 M, pH 4) and
hydrogen peroxide (10 μl/10 ml) added just before use.
An equal volume of 2% SDS was added to stop the reac-
tion and the absorbance was read at 405 nm. The C-
terminal FLAG-BAP™ control protein (Sigma P-7457)
was used to create a standard curve. The amount of
Enfuvirtide peptide present is calculated as a fraction of
the total size of the fusion protein and is presented
as mg Enfuvirtide per grams dry weight where OD600
1 = 0.35 g dry weight (gdw) [12].
Densitometric analysis of the Coomassie blue-stained
SDS-polyacrylamide gels was also used to determine
Enfuvirtide::flagellin fusion concentrations. Gel pictures
were captured using a SynGene G-Box transilluminator
and the GeneSnap version 7.01 software. Concentrations
were determined using Gene Tools version 3.09 soft-
ware. Bacterial alkaline phosphatase::FLAG protein
(Sigma P-7457) at concentrations of 100, 200 and 400
ng was used to generate a standard curve. Peak areas of
Table 1 Bacterial strains and plasmids used in this study
Strain or
plasmid
Relevant characteristics Source or reference
Strains
B. halodurans
BhFD05
Δhag, ΔwprA, ΔfliD, Δalp, Δapr, Δvpr, Δasp Berger et al (2009)
B. halodurans
BhFDL05S
Δhag, ΔwprA, ΔfliD, Δalp, Δapr, Δvpr, Δasp, Δspo0A, ΔlytCE This study
B. halodurans
BhFDL05SC
Δhag, ΔwprA, ΔfliD, Δalp, Δapr, Δvpr, Δasp, Δspo0A, ΔlytCE, ΔclpP This study
B. halodurans
BhFDL05SM
Δhag, ΔwprA, ΔfliD, Δalp, Δapr, Δvpr, Δasp, Δspo0A, ΔlytCE, ΔflgM This study
B. halodurans
BhFDL06S
Δhag, ΔwprA, ΔfliD, Δalp, Δapr, Δvpr, Δasp, Δspo0A, ΔlytCE, ΔaprX This study
E. coli DH10B (F
- mcrA Δ(mrr-hsdRMS-mcrBC) (
80dlacZΔM15)ΔlacX74endA1 recA1 deoR Δ(ara-leu) 7697
araD139 galU galK nupG rpsLl
-
Invitrogen
Plasmids
pSEC194 Cm
R,A p
R, thermosensitive integration vector Crampton et al (2007)
pNW33N E. coli/Bacillus/Geobacillus shuttle vector Bacillus Genetics Stock Centre,
(BGSC) Ohio, USA
pSECFliCFFuz pSEC194, s
D promoter, hag gene (FliC1-275), FLAG tag, enterokinase cleavage site and
Enfuvirtide gene as in-frame fusions
This study
pNWFliCFFuz pNW33N, s
D promoter, hag gene (FliC1-275), FLAG tag, enterokinase cleavage site and
Enfuvirtide gene as in-frame fusions
This study
pNWNCFFuz pNW33N, s
D promoter, truncated hag gene (FliCΔ46-201), FLAG tag, enterokinase cleavage site
and Enfuvirtide gene as in-frame fusions
This study
pNWNFFuz pNW33N, s
D promoter, N- terminal hag gene (FliC1-45), FLAG tag, enterokinase cleavage site
and Enfuvirtide gene as in-frame fusions
This study
pNWCFFuz pNW33N, s
D promoter, ATG, C-terminal hag gene (FliC202-275), FLAG tag, enterokinase cleavage
site and Enfuvirtide gene as in-frame fusions
This study
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protein concentration derived from the standard curve.
This method allows for determination of the relative
levels of the fusion proteins in the medium [6].
Results
Construction of B. halodurans BhFD05 mutant strains
through gene-targeted inactivation
Modifications were made to the genome of B. halodur-
ans BhFD05 to generate a number of strains with differ-
ent genotypes with a view to evaluating their effect on
the flagellin type III secretion pathway. The flagellum is
composed of basal body proteins, proteins that form the
external filament and hook proteins. Assembly of the
flagellar organelle in B. subtilis is coupled to gene tran-
scription and is governed by the flagellar-specific tran-
scription factor s
D and its antagonist, the anti-s
D factor
FlgM [13]. Thus, the genes chosen for inactivation
included transcriptional regulators affecting s
D-depen-
dent gene transcription, as well as proteases, specifically
intracellular and ATP-dependent proteases, in an effort
to further protect heterologous flagellin fusions with
potential proteolytic susceptibility.
Construction of BhFDL05S
The spo0A and lytCE (lytic operon comprising the lytC
and lytE genes) were inactivated on the chromosome of
BhFD05, giving rise to strain BhFDL05S. The Spo0A
protein is a master regulator of the entry of Bacillus sp.
into sporulation [14]. It does, however, also have a
pleiotropic effect on a number of different cellular pro-
cesses, which include protease production [15], motility,
competence for transformation [16] and biofilm forma-
tion [17]. Significant mutation of spo0A was found to
result in abnormally high levels of s
D-dependent gene
transcription [18]. As this is the sigma factor involved in
fliC promoter activity, this gene was inactivated with a
Table 2 List of primers, their corresponding nucleotide sequences and application
Primer name Nucleotide sequence
a Application
SpoIVF CGGAAAGCTTGTTGGTGCAGTGAC Spo0A
SUpR CTAGGATCCGTAAGAGGCTCCTAAATCAACCG Spo0A
SDoF CTAGGATCCGCCATGGTAGCCGATAAGC Spo0A
SDoR CTACCCGGGGATTAATCTGGGCAATGGTTGC Spo0A
UplytCF CTCGGTACCCTTAGAGGAGGGATGAGG LytCE
UplytCR CTCGGATCCACGGATGACGGTCACCAA LytCE
DolytEF CTCGGATCCTTGAACAAAGCCGCTGCA LytCE
DolytER CTCCCCGGGACGGCCGATGCCGCGTTA LytCE
FlgMF GTTAGGTACCGATCATTGTCTAGATTG FlgM
FMNtR CTGCTCGAGCATCTTCACCTCAATTTC FlgM
FMCtF CTGCTCGAGCAAGTAATGAGAGGGGGCTC FlgM
FMCR2 CATCCCGGGTTGAGCGTCACCGTAAC FlgM
ClpUp GTAGGTACCCAGCAGGCTCTAAATGTTG ClpP
ClpUpR GTAGGATCCTCGAGAATAAATGTCATACG ClpP
CDoF GGATCCTCGATGAATGCGATAAGAG ClpP
CDoR GATATCTGTCTATCTTGTCCGCTTG ClpP
LacF CTAGGTACCAATCGCTCACATCTC AprX
AprXR1 CGACTCGAGCTGTACCATGGAATATCC AprX
AprXF2 CTACTCGAGCAGCAGAGGGTGCGATTC AprX
AprXR2 CTACCCGGGGACGATTCCGAGATGAAGCAC AprX
s
DKpn CTCGGTACCCTCGCGTTACGCTCTTTCTGT FliC
FliCendR CGACGGATCCGCACTCGAGACGAAGTAATTGTAATAC FliC
FlagXhoF GAGACTCGAGGAATCTGGAGCAGATTATA FLAG tag
FuzendR2 GTCTAGGATCCTTAAAACCAATTCCATAATG Enfuvirtide
NRev CTTAGTCGACACCTGCAGCATCGTCTCC N-terminal FliC
CFOR CTACGTCGACCGCTCTTACCTAGGAGCT C-terminal FliC
CstartR
FuzF
FuzR
GTCTGTCGACCATTAAAATTTCCTCCTTG
GCTGTCGACATGTATACGTCATTAATTCATTCATTAATTGAAGAATCACAAAATCAACAAGAAAAAAA
TGAACAAGAATTATTAGAATTAGATAAATGGGCATCATT
ATGGAATTGGTTTATGTGGATCCTCG
CGAGGATCCACATAAACCAATTCCATAATGATGCCCATTTATCTAATTCTAATAATTCTT
GTTCATTTTTTTCTTGTTGATTTTGTGATTCTTCAATTAAAGTATGAATTA
ATGACGTATACATGTCGACAGC
C-terminal FliC
Enfuvirtide
Enfuvirtide
a Restriction enzyme sites are underlined.
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[19], however, reported that a B. subtilis spo0A mutant
strain used as a host for extracellular protein production
was found to have significantly low protease activities,
but that these strains were also found to be more prone
to cell lysis. This was attributed to decreases in the
expression levels of extracellular proteases that led to
stabilization of the autolysins. Autolysins are bacterial
enzymes that hydrolyse and remodel the peptidoglycan
found in the bacterial cell walls. In B. subtilis LytC,
LytD and LytF have all been implicated in vegetative cell
separation and cell motility [20]. In a strategy to prevent
autolysis of the cells, Kodama et al [19] was able to
show that inactivation of the major autolysin LytC was
effective in preventing cell lysis of a spo0A mutant strain
in B. subtilis. Consequently, both the spo0A gene and
lytCE operon of B. halodurans was inactivated and their
effect on the cells with regards to type III secretion, as
well as cell lysis was evaluated.
Construction of BhFDL05SM
The flgM gene was deleted on the chromosome of
BhFDL05SM, giving rise to strain BhFDL05SM. In enteric
bacteria, the genes involved in flagellar synthesis and
assembly can be grouped into three tiers. Class I includes
the master genes flhDC, which are absolutely required for
expression of class II genes, encoding the structural com-
ponent of the hook-basal body (HBB) complex. The
expression of class III genes encoding hook-associated
proteins, flagellin, motor components and the chemotaxis
apparatus is dependent upon completion of the HBB
complex. Coupling of class III gene expression to HBB
complex assembly is achieved through action of FlgM, an
anti-sigma factor. In B. subtilis a similar hierarchy of
genes involved in flagellar synthesis and assembly can be
identified, even though no master operon corresponding
to class I genes of enterobacteria has been described. By
analogy to E. coli and S. typhimurium, genes involved in
the HBB complex are grouped into class II, and genes
whose expression is dependent on class II genes are con-
s i d e r e dt ob e l o n gt oc l a s sI I I .C l a s sI I Ig e n e sc o n s t i t u t e
the s
D regulon, since they are transcribed uniquely from
promoters recognized by the s
D initiation factor. The s
D
regulon includes genes involved in flagellar synthesis,
motility, chemotaxis, autolysis and regulation of gene
expression. Caramori et al [21] found that in B. subtilis
FlgM is a major regulator of s
D-dependent promoters; in
the absence of FlgM not only a strong increase in the
expression of s
D-dependent promoters was observed, but
also prolonged expression, protracted into the stationary
phase. They speculated that FlgM may be involved in the
temporal control of late flagellar gene expression. In
order to determine whether this is the case in B. halodur-
ans the flgM gene was deleted and its effect on recombi-
nant peptide expression evaluated.
Construction of BhFDL06S and BhFDL05SC
The intracellular protease gene (aprX)a n dt h eA T P -
dependent clpP protease gene of B. halodurans BhFDL05S
were both deleted, giving rise to strains BhFDL06S and
BhFDL05SC, respectively. Kodama et al [22] found that
aprX was transcribed during stationary phase growth and
the protease activity of AprX was detected in the culture
medium of B. subtilis due to cell lysis. It was therefore
decided to inactivate the aprX gene with a view to increas-
ing the stability of the recombinant peptide in the extracel-
lular medium.
In B. subtilis, Clp proteases are the main components
of ATP-dependent degradation and Clp mutants show
highly pleiotropic phenotypes. They are complexes in
which the core is composed of the ClpP protein with
low intrinsic proteolytic activity. In the complex with a
hexameric ATPase, both high proteolytic activity and
substrate specificity is conferred. No common sequence
motifs could be determined for recognition by Clp pro-
teases and Krűger et al [23] were able to show that Clp
proteases participate directly in overall proteolysis of
misfolded proteins. Pummi et al [24] investigated the
role of Clp proteases in protein secretion and found that
inactivation of ClpP improved the secretion of a hetero-
logous protein by B. subtilis.
Evaluation of different host strain backgrounds with
regard to the flagellin-specific export pathway
The B. halodurans strains BhFDL05S, BhFDL05SC,
BhFDL05SM and BhFDL06S were all transformed with
pSECFliCFFuz (Table 1). These strains were evaluated
in shake flask studies by comparing expression levels of
recombinant flagellin fusion proteins secreted into the
1        45       202      275
ıD
ıD
ıD
pSECFliCFFuz
pNWNCFFuz
pNWNFFuz
pNWCFFuz ıD
ıD pNWFliCFFuz
Figure 1 Schematic representation of the flagellin fusion
constructs containing different regions of the FliC protein
fused to the FLAG tag and the Enfuvirtide peptide (Fuz)
expressed in B. halodurans BhFDL05S. The numbers indicate the
size (amino acids) of the different fragments of the FliC protein
used for the different constructs. The different colour blocks indicate
the different regions of the FliC protein: the full-length flagellin
protein (FliC1-275), the N-terminal region (FliC1-45) in blue, the C-
terminal region (FliC202-275) in yellow and a truncated version with
157 amino acids of the central variable region (grey) deleted
(FliCΔ45-275). The red block indicates a FLAG tag and the green block
the Enfuvirtide (Fuz) peptide. An enterokinase cleavage site was
inserted between the FLAG tag and Enfuvirtide peptide.
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as described in the methods section. Cell-free culture
supernatants and intracellular fractions were harvested
at 16 h and 20 μl aliquots separated on an SDS-polya-
crylamide gel (Figure 2A) and the fusion proteins were
identified by Western blot (Figure 2B). In the publica-
tion of Berger et al (8) all the samples analysed on SDS-
PAGE gels were concentrated cell-free supernatants,
however in this study all samples evaluated were crude
(non-concentrated) cell-free culture supernatants. The
amount of flagellin fusion peptide secreted was analysed
at various time points using an ELISA plate assay, as
described in the Methods section, and actual Enfuvirtide
peptide was calculated as mg of actual Enfuvirtide pep-
tide per gram dry weight (mg/gdw) (Figure 3). From
Figure 3 it can be seen that strain BhFDL05S with the
spo0A gene and the lytic operon deleted showed the
greatest improvement in the secretion of recombinant
peptides, as compared to the parental strain BhFD05.
This was followed by strains BhFDL05SM with the flgM
gene deleted, and BhFDL06S with the intracellular pro-
tease gene aprX deleted. Strain BhFDL05SC with the
clpP gene deleted showed the least improvement in pep-
tide secretion.
The samples analysed in Figure 2A and 2B were evalu-
ated by Western blot for the presence of chlorampheni-
col acetyltransferase in the cell-free supernatant
fractions which would indicate cell lysis (Figure 2C).
The marker protein was only detected in the intracellu-
lar fraction of the control strain BhFDL05S containing
the plasmid pSEC194. This indicates that the heterolo-
gous fusion proteins were indeed secreted and that cell
lysis did not occur during this time period. Thus, strain
BhFDL05S was found to be the most efficient in secret-
ing recombinant peptides via the flagellin type III secre-
tion pathway and was therefore used as host strain for
the evaluation of different constructs.
Rationale for construct development
The export substrates of type III export systems do not
contain cleavable signal sequences and they do not
kDa
55
35
Cell-free supernatant                          Intracellular
A
S       I        S      I        S      I       S      I        S      I
kDa
55
35
B
kDa
36
C
S    S     S     S    S           Intracellular
1      2       3
Figure 2 SDS-PAGE and Western blot analysis of different
fractions of B. halodurans recombinant strains transformed
with plasmid pSECFliCFFuz. (A) SDS-PAGE (12%) analysis of 16 h
crude cell-culture supernatants (20 μl) and intracellular fractions (20
μl) from the different B halodurans strains as indicated above each
lane. (B) Western blot analysis of the same samples as in A using
Anti-FLAG monoclonal antibodies. The letter S indicates cell-free
culture supernatant and I intracellular fraction. (C) Western blot
analysis with an antibody to chloramphenicol acetyltransferase as a
test for cell lysis. The crude cell-free supernatants (S) are the same
as in A and the intracellular fractions are from control strain
BhFDL05S (pSECFliCFFuz), lane 1; BhFDL05S (pSEC194), lane 2 and
negative control BhFDL05S without plasmid, lane 3. The arrow
indicates the expected size for chloramphenicol acetyltransferase (35
kDa). The molecular weight markers in kDa are indicated on the left.
Figure 3 Comparison of amount of Enfuvirtide peptide (mg/
gdw) produced in the different B. halodurans strains
containing pSECFliCFFuz. An ELISA plate assay using Anti-FLAG
antibodies was used to determine the concentration of fusion
protein produced in the culture supernatants of the different strains
at selected time points. The amount of Enfuvirtide peptide was
calculated and presented as mg Enfuvirtide per grams dry weight.
The error bars show the ± SD of three separate experiments.
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However, both Majander et al [4] and Végh et al [5]
have identified different flagellum-specific secretion
signals in two Gram-negative bacteria, E. coli and
Salmonella, respectively, which they attribute towards
mediating the secretion of flagellin through the flagel-
lar export pathway. In E. coli this was identified as a
173-bp untranslated DNA fragment upstream of the
fliC gene, and in Salmonella as a 22-residue long
segment within the disordered N-terminal region of
Salmonella flagellin. With this in mind, constructs
were designed to contain the s
D promoter region, full-
length B. halodurans flagellin protein corresponding to
amino acids 1-275 (FliC1-275), the N-terminal region
(FliC1-45) of the, the C-terminal region (FliC202-275),
and a truncated version of the flagellin protein with
157 amino acids of the central variable region deleted
(FliCΔ46-201)( F i g u r e1 ) .A nE. coli/Bacillus/Geobacillus
shuttle vector pNW33N was used to replace the
pSEC194 vector, as it does not harbour a temperature
sensitive ori of replication and was found to stably
replicate in B. halodurans due to the presence of the
cryptic replicon pBC1.
Evaluation of the secretion efficiency of different
constructs in B. halodurans strain BhFDL05S
All the constructs were transformed into strain
BhFDL05S and were evaluated in shake flask studies by
comparing expression levels of flagellin fusion proteins
secreted into the supernatants over a 24 h period.
Actual peptide concentrations were calculated to com-
pensate for the size differences of the different peptide
fusion constructs. Samples were taken and analysed as
previously described. At 16 h, aliquots were separated
o naS D S - P A G Eg e l( F i g u r e4 A )a n dt h e na n a l y s e db y
W e s t e r nb l o t( F i g u r e4 Ba n d4 C ) .F r o mt h er e s u l t si n
Figure 5, it can be seen that the best construct in terms
of peptide secretion is pNWNCFFuz, followed by
pNWFliCFFuz and pSECFliCFFuz. The construct
pNWNFFuz, containing only the N-terminal region of
the flagellin protein, was found to secrete low levels of
peptide into the medium, while for pNWCFFuz, con-
taining only the C-terminal region, no recombinant pep-
tide could be detected. The pNW33N vector
replacement greatly benefitted expression, as did utiliz-
ing the truncated flagellin construct containing frag-
ments of both the N- and C- terminal regions. Assays
done on intracellular samples of BhFDL05S harbouring
the different constructs showed very low levels of pep-
tide intracellular (results not shown). The Coomassie
blue-stained SDS-PAGE gel (Figure 4A) was subjected
to densitometric analysis. The amount of actual Enfuvir-
tide peptide was calculated as a percentage of the total
fusion protein (Table 3).
Discussion
Most peptides are produced chemically by solid-phase
and liquid phase synthesis, however, the longer the pep-
tide the higher the cost of synthesis, as well as problems
encountered with regard to chain aggregation. This
leads to the formation of truncated peptides, which,
in turn, impact on purification and yield. Microbial
A
55
27
15
kDa
35
B C
Figure 4 SDS-PAGE and Western blot analysis of cell culture
supernatants of B. halodurans BhFDL05S expressing different
constructs.( A) SDS-PAGE (15%) analysis of culture supernatants
taken from 16 h cultures. The first three lanes each contained crude
supernatant (20 μl) and lane 4 (pNWNFFuz) contained concentrated
culture supernatant (equivalent to 250 μl of crude supernatant). This
was due to relatively low concentrations of the fusion peptide. (B)
Western blot analysis of same samples in (A) using Anti-FLAG
monoclonal antibodies. (C) Western blot analysis of pNWFliCFFuz
(38.2 k Da), pNWNCFFuz (19.8 k Da) and pNWNFFuz (10.5 k Da) with
Anti-Enfuvirtide polyclonal antibodies. The amount of sample used
for the Western blot was half of that used for the SDS-PAGE gel.
Molecular weight markers in kDa are indicated on the left.
Figure 5 Comparison of amount of Enfuvirtide peptide (mg/
gdw) produced in B. halodurans BhFDL05S containing different
expression cassettes. The amount of Enfuvirtide peptide was
calculated and presented as mg Enfuvirtide per grams dry weight.
The error bars show the ± SD of three separate experiments.
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Page 7 of 10expression systems continue to be widely used in indus-
try. Their intrinsic advantages such as rapid growth,
high yields and ease of manipulation make them the
premier choice for expression of non-glycosylated pep-
tides and proteins [25]. We have developed an expres-
sion system focussed on the secretion of peptides and
small proteins, which are vulnerable to proteolysis and
therefore need to be expressed as protein fusions so as
to enhance stability. In an effort to address the need for
a cost-effective fermentation-based process for recombi-
nant peptide production, we therefore evaluated the
secretion of a therapeutic peptide, Enfuvirtide, by the B.
halodurans flagellin type III secretion system through
modification of both the host strain and expression
cassette.
Initially, a number of different genetically engineered
strains of B. halodurans BhFD05 were compared. The
secretion efficiency of the fusion proteins was deter-
mined by comparing the levels of the recombinant
peptide present in the medium, as determined by
the ELISA assay. Our results clearly show that the
BhFDL05S strain with both the spo0A and lytCE lytic
operon deleted gave rise to the highest concentration of
recombinant peptides in the supernatant. This was
probably due to the increased levels of s
D-dependent
gene transcription, as reported by Fawcett et al [18] to
occur in Bacillus,a ss
D is the major sigma factor
involved in hag gene transcription encoding not only
the flagellin protein but also genes encoding proteins for
flagellar synthesis, motility and chemotaxis [26]. The
inactivation of the lytic operon was also found to
enhance the stability of the cells and prevent cell lysis,
as the intracellular protein marker, chloramphenicol
acetyltransferase, could not be detected in the superna-
tant after 24 h of growth when evaluated by Western
blot. The inactivation of flgM on the chromosome of
strain B. halodurans BhFDL05S did not lead to a further
increase in protein production. This could possibly be
due to the pleiotropic effect of the Δspo0A background.
This would, however, need to be confirmed by tran-
scriptomic and proteomic results. In contrast, inactiva-
tion of the intracellular protease aprX (strain BhFDL06)
and the clpP protease (strain BhFDL05SC) did not play
a significant role in improving recombinant protein
levels.
A number of constructs were compared for their abil-
ity to secrete the recombinant peptide fusions using the
modified type III flagellin pathway of strain BhFDL05S.
Previous studies with regard to Gram-negative bacteria
suggested that the signal sequence is found at the
mRNA level [27,4] or that a combination of an N-term-
inal signal and a structural element in the mRNA is
required [28]. Alternatively, the signal is contained at
the protein level and is located at or near the N termi-
nus [5,29-32]. In contrast to these findings in Gram-
negative bacteria, we found that a construct encoding a
truncated flagellin gene fused to the Enfuvirtide peptide
with both the N-terminal and C-terminal regions pre-
sent was best able to mediate the secretion of fusion
peptide into the supernatant. The N-terminal region
contained the 22-residue long segment identified by
Végh et al [5] as containing the recognition signal for
the flagellar export machinery. In this study, all the con-
structs also contained 230 bp of untranslated sequence
upstream of the fliC gene in the s
D-promoter region,
which Majander et al [4] claimed facilitated the extracel-
lular secretion of polypeptides via the type III pathway
in E. coli.
Low levels of peptide could be detected in the super-
natant with the construct containing only the N-term-
inal region (pNWNFFuz) and none could be detected
with the construct containing only the C-terminal
region (pNWCFFuz). Intracellular levels were extremely
low for constructs pNWFliCFFuz and pNWNCFFuz and
none for pNWNFFuz and pNWCFFuz (results not
shown). Majander et al [4] reported that N-terminal
polypeptides lacking the C-terminus were efficiently
secreted when the corresponding gene fragments were
e x p r e s s e df r o mt h efliC promoter, but remained within
the cell when non-natural promoters were used. How-
ever, we found that in B. halodurans a combination of
both N- and C-terminal regions are necessary in order
to be able to successfully secrete increased levels of fla-
gellin-peptide fusions. With the C-terminal region alone,
Table 3 Densitometric analysis of the fusion proteins from the Coomassie blue-stained SDS-PAGE gel (mg/L), as
compared to ELISA results (mg/gdw)
Construct name Fusion protein
(mg/L)**
Enfuvirtide peptide
(mg/L)*
Enfuvirtide peptide (mg/gdw)
pSECFliCFFuz 18.5 1.8 0.7
pNWFliCFFuz 32.9 3.3 1.3
pNWNCFFuz 61.0 13.4 2.8
pNWNFFuz 2.6 1.3 0.3
pNWCFFuz ND ND 0
*Enfuvirtide peptide calculated as a percentage of total fusion protein.
**Results quoted as the average of three experiments.
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Page 8 of 10no flagellin fusion peptide was observed, either intra- or
extracellularly, indicating that the C-terminal fusion is
unstable. However, it has been proposed that in the
Gram-negative flagellar system the C-terminal region of
the flagellin protein is involved in the chaperone bind-
ing, therefore playing a role in the stabilization of the
flagellin monomers from proteolytic activity, as well as
in prevention of premature folding and in the timing of
secretion of the flagellin monomers from the cytoplasm
[33,34].
A major advantage of secreted protein expression is
that cell disruption is no longer required before purifica-
tion and the starting material is less contaminated with
host proteins, lipopolysaccharides and nucleic acids. The
constructs contain a FLAG-tag that enables easy detec-
tion and purification, and an enterokinase cleavage that
facilitates selective removal of the peptide of interest.
Our system utilizes an endogenous promoter and there-
fore no inducers need to be added to the medium.
Yields of actual peptide were calculated from peptide
fusions in the supernatant using the ELISA assay, which
allows for a comparative determination of peptide yields
between the different constructs. Strain optimization
increased actual peptide levels by almost 10-fold and
cassette optimization contributed a further 3.5-fold
increase. In addition, we evaluated peptide fusion con-
centrations using densitometric analysis that was also
used to determine secretion levels obtained from either
the Salmonella or E. coli flagellar type III systems. Since
t h ea m o u n to fC o o m a s s i eb l u es t a i nb o u n dt ot h es a m e
amounts of a range of proteins might differ, this method
is not directly comparable. It is, however, of interest to
note that with the E. coli secretion system peptide
fusions of between 1 and 15 mg/L were obtained in the
supernatant. However, the Peb1 protein, which was
f o u n dt ob es e c r e t e da tt h eh i g h e s tl e v e l s ,w a sa l s o
recently found to be actively secreted by E. coli in a fla-
gellar-independent manner by an unknown two-step
process [35]. In the Salmonella system, a range of differ-
ent protein fusions, eighteen in total, were found to be
secreted at levels varying between < 1 and 4 mg/L. A
number of these were found to form intracellular aggre-
gates. From densitometric analysis of recombinant fla-
gellin fusions secreted by B. halodurans, concentrations
of 61 mg/L of peptide fusions were obtained after 16 h
using strain BhFDL05S expressing the pNWNCFFuz
construct. This translates into approximately 13 mg/L of
actual peptide being secreted as a fusion in shake flask
cultures. No intracellular aggregates were identified with
this construct. Cleavage by enterokinase is designed to
yield the authentic amino-terminus of the peptide as no
additional amino acids remain on the N-terminal region
of the peptide after cleavage, thereby allowing for the
chemical modification step to follow. This is a promising
result for biotechnological applications, as there is clearly
potential for further optimization through fermentation
studies.
Conclusions
The type III flagellar secretion system of B. halodurans
has been shown to successfully secrete a therapeutic
peptide as a flagellin fusion polypeptide, giving rise to
possibilities for biotechnological applications using this
novel engineered production host. Our results demon-
strate that chromosomal inactivation of both the spo0A
gene and the lytic operon increased the levels of the
secreted peptide fusions. In addition, further improve-
ment in the concentration of the secreted fusion pep-
tides was achieved by the incorporation of both the N-
terminal and C-terminal flagellin regions of the flagellin
monomer in structuring an optimized cassette on a
multi-copy vector. In shake flask studies, strain
BhFDL05S expressing the pNWNCFFuz construct, was
shown to secrete 61 mg/L of peptide fusions into the
supernatant after 16 h, which translates into approxi-
mately 13 mg/L of actual Enfuvirtide peptide.
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